The new memecoin player Little Pepe nears the end of its presale, raising over $26 million as Stage 13 sells out quickly. #partnercontentThe new memecoin player Little Pepe nears the end of its presale, raising over $26 million as Stage 13 sells out quickly. #partnercontent

Little Pepe presale nears completion with $26m raised

Disclosure: This article does not represent investment advice. The content and materials featured on this page are for educational purposes only.

Little Pepe nears the end of its presale, raising over $26 million as Stage 13 sells out quickly.

Summary
  • The Little Pepe presale has raised $26.3m of its $28.7m goal, with more than 16.1b tokens already sold.
  • Investors from the earliest stages are sitting on gains of around 120% even before the token hits exchanges.
  • Large-investor accumulation, rapid stage sellouts, and large-scale giveaways continue to drive strong community engagement.

Little Pepe (LILPEPE) is in the spotlight. Its presale is almost sold out at $0.0022 per token, raising $26.3 million of its $28.77 million goal. More than 16.1 billion tokens have already been sold, with Stage 13 now over 93% sold out.

Price growth and presale momentum

LILPEPE has increased in price from $0.0021 in the previous stage to $0.0022 currently. Early buyers from Stage 1 are already sitting on gains of about 120% without even hitting the open market. This presale momentum is often an early signal that the community is engaged and willing to commit fresh capital. Momentum has been driven by how quickly each stage has sold out. Stage 12 closed earlier than expected, and now Stage 13 is moving just as fast.

Accumulation and early confidence

The presence of strong big-investor accumulation has become a central part of the LILPEPE story. Large buyers entering early often signal that they believe the project has long-term potential. Their willingness to hold their positions rather than sell immediately after launch could help support the price during the volatile first weeks on exchanges. For smaller investors, this pattern often feels reassuring because it hints that experienced crypto players are willing to take a significant stake in the project.

Community incentives and cultural buzz

One of the reasons LILPEPE’s presale has remained in the headlines is its $777,000 giveaway, which has already drawn more than 422,400 entries. Ten winners from this promotion will each receive $77,000 worth of LILPEPE tokens. Alongside this is the Mega Giveaway, which is running in stages 12 to 17 and has attracted over 74,000 entries so far. These campaigns have created real excitement, making LILPEPE feel more like a movement than just a token sale.

Zero market cap advantage and exchange listings

One of the biggest factors working in LILPEPE’s favor is that it is starting from a nearly zero market capitalization. Tokens that launch from scratch often have more room to climb compared to established giants, whose massive valuations make similar leaps harder to achieve. The team has also focused on building real infrastructure rather than relying only on hype.

LILPEPE is developing its own Layer 2 solution tailored for meme tokens, aiming to cut costs and speed up transactions. It has been audited by Certik for added credibility and is built with sniper bot resistance to prevent whales from taking an unfair advantage during trading. Excitement is also growing around its preparation for centralized exchange listings.

Conclusion

Little Pepe has shown that it is more than just another memecoin. Its presale progress, big-investor backing, innovative features, and massive giveaways have helped it capture attention in a crowded market. The token’s launch from a near-zero market cap gives it a rare opportunity for significant growth if all the pieces fall into place.

For anyone interested in joining before the presale ends, visit the Little Pepe website, join the Telegram community, follow its updates on Twitter, or learn how to enter the $777k Giveaway while the final presale stages remain open.

Disclosure: This content is provided by a third party. Neither crypto.news nor the author of this article endorses any product mentioned on this page. Users should conduct their own research before taking any action related to the company.

Market Opportunity
Pepe Logo
Pepe Price(PEPE)
$0.000005817
$0.000005817$0.000005817
-2.39%
USD
Pepe (PEPE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23